Avis spéciaux : Mises à jour de MI4 sur la COVID-19

CRP timeline Sept 12

MI4 has contributed to the funding of the Clinical Research Platform, where research efforts were underway early and our investigators are now part of several Clinical Trials. Platform director for the McGill University Health Centre site is Dr. Marina Klein and Dr. Christina Greenaway directs the Jewish General Hospital site.

CL3 Timeline Sept 14

MI4 contributed to the funding of a Containment Laboratory Level 3 platform where handling of SARS-COV-2 virus can be performed in a safe manner. The MUHC CL3 site Director is Dr. Marcel Behr and the Bellini site is directed by Dr. Silvia Vidal.

Vous trouverez ci-dessous des mises à jour et de l'information (en anglais) de la communauté de MI4 au sujet de la COVID-19 :

2021-06-22: CMAJ news | Patient partnership falling to wayside in COVID-19 research rush
2021-05-12: McGill News | McGill-Concordia-uOttawa research team finds correlation between COVID-19-based discrimination and poor mental health
2021-04-21: Sages Journals | Evaluations of Healthcare Providers’ Perceived Support From Personal, Hospital, and System Resources: Implications for Well-Being and Management in Healthcare in Montreal, Quebec, During COVID-19
2021-04-21: Sages Journals | Evaluations of Healthcare Providers’ Perceived Support From Personal, Hospital, and System Resources: Implications for Well-Being and Management in Healthcare in Montreal, Quebec, During COVID-19
2021-04-14: McGill University | Principal Prize for Public Engagement through Media recognizes several MI4 researchers and is awarded to Don Sheppard
2021-02-22: La Presse « Empêcher l’incendie de forêt » à Montréal-Nord For additional coverage, see these news and broadcast reports: CTV News, 800 CJAD, ICI Radio-Canada Première
2021-02-17: MUHC Foundation HONOURING LEADERSHIP EXCELLENCE IN MONTREAL WITH A $1 MILLION DONATION
2021-01-18: McGilMcGill Fac of Medicine Alumni & Friends l NURSES AND PHYSICIANS’ DISTRESS, BURNOUT, AND COPING STRATEGIES DURING COVID-19
2021-01-18: Ici Radio Canada Le prix de scientifiques de l’année 2020 aux modélisateurs de la pandémie: quatre d’entre eux se partagent le prix incluant Mathieu Maheu-Giroux
2021-01-12: Annals of Internal Medicine The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis
2020-12-29: INESS SUIVI DE L’ÉVOLUTION DE L’ÉPIDÉMIE DE COVID-19 ET DES BESOINS HOSPITALIERS AU QUÉBEC
2020-12-24: medrxiv A Neanderthal OAS1 isoform Protects Against COVID-19 Susceptibility and Severity: Results from Mendelian Randomization and Case-Control Studies
2020-12-16: Evaluation of a home-based 7-day infection control strategy for healthcare workers following high-risk exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2): A cohort study
2020-12-04: McGill Health eNews Pfizer Canada donation will help new researchers change the future
2020-11-19: Can J Public Health Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective
2020-11-06: medRxiv Evaluation of a home-based 7-day infection control strategy for healthcare workers following high-risk exposure to SARS-CoV-2: a cohort study
2020-11-03: PlosOne Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis
2020-10-28: Advanced Materials SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination
2020-10-27: Education News Canada McGill co-founded grassroots organization receives major gift to continue COVID-19 fight: $250k donation will enable group to expand its efforts
2020-10-23: ISDA Real-world Time to Positivity of 2 Widely Used Commercial Blood Culture Systems in Patients With Severe Manifestations of Sepsis: An Analysis of the FABLED Study
2020-10-19: CMAJ Générer des données d’essais randomisés pour optimiser le traitement à l’ère de la pandémie de COVID-19
2020-10-08: GlycoNet announces new Directors to the Board including Don Sheppard
2020-10-05: CMAJ Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs
2020-10-02: JMIR Remote monitoring technologies (RMT) used to support COVID-19 patients: A rapid review
2020-09-29: New $200M MUHC Foundation campaign aims to boost COVID-19 research in Montreal
2020-09-28: J Gen Intern Med Expert Forecasts of COVID-19 Vaccine Development Timelines
2020-09-24: Science Auto-antibodies against type I IFNs in patients with life-threatening COVID-19
2020-09-24: Science Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020-09-24: MUHC News 15,000 COVID-19 tests produced by McGill University and the RI-MUHC: a step towards Canadian self-sufficiency 15 000 tests de dépistage de la COVID-19 fabriqués par l’Université McGill et l’IR-CUSM: un pas vers l’autosuffisance canadienne
2020-09-23: McGill Health e-News Containment Level 3 facilities advance COVID-19 research at McGill
2020-09-21: Ultrasound Obstet Gynecol Pregnancy and COVID-19: Pharmacologic Considerations
2020-09-21: The Montrealer Trottier Family Foundation gift empowers Montreal’s most affected communities to fight COVID
2020-09-09: CMAJ Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs
2020-08-31: COVID19 Vaccine Tracker An interactive map by country indicates ongoing COVID-19 vaccine clinical trials. Details are shown on each of the COVID-19 vaccine candidates evaluated in clinical trials.
2020-08-23: Open Forum Infect Dis Real-world Time to Positivity of 2 Widely Used Commercial Blood Culture Systems in Patients With Severe Manifestations of Sepsis: An Analysis of the FABLED Study
2020-08-23: The COVID-19 Immunity Task Force, funded by the Government of Canada, brings together university, hospital and public health expertise to map the scope of coronavirus infection in Canada. MI4 Members include. Drs. Bruce Bazer, Matthew Pellan Cheng, Jesse Papenburg, Cedric Yansouni
2020-08-06: N Engl J Med. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
2020-08-04: Lancet Infect Dis SeroTracker: a global SARS-CoV-2 seroprevalence dashboard
2020-08-04: SeroTracker MI4 members Matthew Cheng and Jesse Papenburg are members of the Scientific Advisors and Collaborators
2020-07-23: medRxiv Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19
2020-07-20: medrxiv Importation of SARS-CoV-2 following the "semaine de relâche" and Québec's (Canada) COVID-19 burden - a mathematical modeling study
2020-07-16: Ann Intern Med. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial
2020-07-03: Trials Comparison of two methods to clear the airways of critically ill children and adults with COVID-19 infection: a structured summary of a study protocol for a pilot randomized controlled trial
2020-07-01: BMJ Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
2020-06-23: ACS Publications Hydrophilic Mechano-Bactericidal Nanopillars Require External Forces to Rapidly Kill Bacteria
2020-06-19: Comparative grid of provincial health emergency powers in Canada analysis_grid_emergency_powers.pdf
2020-05-22: INESSS INESSS, INSPQ, Équipe de modélisation de l’Université McGill (2020). Projections du nombre d’hospitalisations pour les personnes atteintes de la COVID-19 au 22 mai 2020.
2020-05-07: Can J Anaesth. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial
2020-05-04: Results of MI4 Emergency COVID-19 Research Funding (ECRF) - Round 2
2020-04-25: INSPQ INESSS, INSPQ, Équipe de modélisation de l’Université McGill (2020). Projections du nombre d’hospitalisations pour les personnes atteintes de la COVID-19 au 25 avril 2020.
2020-04-23: Government of Canada announces major steps in treating and preventing COVID-19 through vaccines and therapies: MI4 members Youla S. Tsantrizos, Don Vinh, Makeda Semret and Don Sheppard are on the COVID-19 Therapeutics Task Force
2020-04-14: CMAJ Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic
2020-04-14: Dr Don Sheppard discute de la pandémie de COVID-19 au CBC Radio's Let's Go with Sabrina Marandola
2020-03-31: Lancement du site COVID-19 Resources Canada
2020-03-31 : Appel de propositions de MI4 : 2e ronde - Financement d'urgence de la recherche sur la COVID-19 (fermé)
2020-03-31 : Résultats de la 1re ronde de financement d'urgence de la recherche sur la COVID-19
2020-03-31 : Deuxième série de questions-réponses au sujet de la COVID : webémission spéciale - Dr Marcel Behr et Dr Timothy Evans
2020-03-20 : Appel de propositions de MI4 : Financement d'urgence de la recherche sur la COVID-19 (fermé)
2020-03-19 : Faire face à la COVID-19 : webémission spéciale - Les Drs Marcel Behr et Timothy Evans répondent à des questions pressantes sur la pandémie de COVID-19
2020-03-12 : Lettre ouverte de MI4 - COVID-19 (transmission communautaire et salles de classe)
2020-02-05 : Le coronavirus en contexte : webémission spéciale - Les Drs Timothy Evans et Chen Liang répondent à des questions et discutent des risques, des défis et des perspectives à long terme associés à l'éclosion de coronavirus

De plus, vous trouverez les dernières informations de l'Université McGill et d'autres sources sur les sites suivants :

Main navigation

Avis spéciaux : Mises à jour de MI4 sur la COVID-19

Department and University Information

Initiative interdisciplinaire en infection et immunité de l’Université McGill